|
Methoxsalen Related Compound A (25 mg) (4-Methoxy-7H-furo[3,2-g]chromen-7-one)
|
|
|
Metomidate Hydrochloride (50 mg) (Methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate hydrochloride)
|
|
|
[Met(O)14]-Exenatide (1 mg)
|
|
|
Mafenide Related Compound A (50 mg) (4-Formylbenzenesulfonamide)
|
|
|
Methoxsalen Related Compound B (25 mg) (4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one)
|
|
|
Mafenide Acetate (200 mg)
|
|
|
Magnesium Carbonate (2 g)
|
|
|
Magnesium Chloride (1 g)
|
|
|
Magnesium Hydroxide (1 g)
|
|
|
Magnesium Phosphate (2 g) (AS)
|
|
|
Magnesium Salicylate (200 mg)
|
|
|
Magnesium Stearate (DISCONTINUED)
販売終了
|
|
|
Magnesium Sulfate (1 g) (Magnesium Sulfate (1:1) heptahydrate)
|
|
|
Malathion (500 mg)
|
|
|
Maleic Acid (300 mg)
|
|
|
Malic Acid (500 mg)
|
|
|
Maltitol (200 mg)
|
|
|
Maltol (500 mg)
|
|
|
Maltose Monohydrate (500 mg)
|
|
|
Maltotriose (500 mg)
|
|
|
Mandelic Acid (500 mg)
|
|
|
Mannitol (1.5 g)
|
|
|
Manganese Chloride (AS)
販売終了
|
|
|
Manganese Sulfate (1 g) (AS) (DISCONTINUED)
販売終了
|
|
|
Mannose (500 mg)
|
|
|
Maprotiline Hydrochloride (200 mg)
|
|
|
Maprotiline Related Compound D (15 mg) (3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine, hydrochloride)
|
|
|
Mebendazole (200 mg)
|
|
|
Mebendazole Related Compound D (15 mg) (Methyl 5-benzoyl-1-methylbenzimidazol-2-ylcarbamate)
|
|
|
Mebrofenin (100 mg)
|
|
|
Mecamylamine Hydrochloride (200 mg)
|
|
|
Mecamylamine Related Compound A (10 mg) (N,1,7,7-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride)
|
|
|
Meclizine Hydrochloride (500 mg)
|
|
|
Meclizine Related Compound A (15 mg) (4-Chlorobenzhydrol)
|
|
|
Meclizine Related Compound B (15 mg) (1-[(4-Chlorophenyl)(phenyl)methyl]-4-(2-methylbenzyl)piperazine dihydrochloride monohydrate)
|
|
|
スルホサリチル酸メクロサイクリン
販売終了
|
|
|
Meclofenamate Sodium (500 mg)
|
|
|
Medroxyprogesterone Acetate (200 mg)
|
|
|
Medroxyprogesterone Acetate Related Compound A (25 mg) (6alpha-Methyl-3,20-dioxopregnan-17-yl acetate)
|
|
|
Mefloquine Hydrochloride (100 mg)
|
|
|
Mefloquine Related Compound A (20 mg) (threo-mefloquine)
|
|
|
Megestrol Acetate (250 mg)
|
|
|
Megestrol Acetate Related Compound C (20 mg) (6,17a-beta-Dimethyl-3,17-dioxo-17a-homoandrosta-4,6-diene-17a-alpha-yl acetate)
|
|
|
Megestrol Acetate Related Compound D (20 mg) (6-Methylene-3,20-dioxopregn-4-en-17-yl acetate)
|
|
|
Meglumine (500 mg)
|
|
|
Megestrol Acetate Related Compound H (20 mg)
|
|
|
Melamine (250 mg) (2,4,6-Triamino-1,3,5-triazine)
|
|
|
Melengestrol Acetate (125 mg)
|
|
|
Melengestrol Acetate Related Compound A (25 mg) (16-Methylene-3,20-dioxopregn-4-en-17-yl acetate)
|
|
|
Melengestrol Acetate Related Compound B (25 mg) (6,16-Dimethylene-3,20-dioxopregn-4-en-17-yl acetate)
|
|
|
Meloxicam (400 mg)
|
|
|
Meloxicam Related Compound A (25 mg) (ethyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate- 1,1-dioxide)
|
|
|
Meloxicam Related Compound B (25 mg) (5-Methylthiazol-2-amine)
|
|
|
Meloxicam Related Compound C (30 mg) (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide)
|
|
|
4-Methoxymeloxicam (30 mg) (4-methoxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide)
|
|
|
(Z)-N'-Methylmeloxicam (30 mg) ((Z)-N-(3,5-dimethylthiazol-2(3H)-ylidene)-4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide)
|
|
|
Mefenamic Acid (200 mg)
|
|
|
Melatonin (150 mg)
|
|
|
Melatonin Related Compound A (15 mg) (2-(5-methoxy-1H-indol-3-yl)ethanamine)
|
|
|
Memantine Hydrochloride (150 mg)
|
|
|
Memantine Related Compound A (50 mg) (1,3-Dimethyladamantane)
|
|
|
Memantine Related Compound B (15 mg) (3,5-Dimethyladamantane-1-ol)
|
|
|
Memantine Related Compound C (50 mg) (1-Chloro-3,5-dimethyladamantane)
|
|
|
Memantine Related Compound D (50 mg) (1-Bromo-3,5-dimethyladamantane)
|
|
|
Memantine Related Compound E (15 mg) (N-3,5-Dimethyladamantan-1-yl formamide)
|
|
|
Menadione (200 mg)
|
|
|
Menaquinone-4 (50 mg) (2-Methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthalene-1,4-dione) (COLD SHIPMENT REQUIRED)
|
|
|
Menaquinone-7 (3 x 50 mg) (Vitamin K2)
|
|
|
メンハーデンオイル
販売終了
|
|
|
Menthol (250 mg)
|
|
|
メフェニトイン
販売終了
|
|
|
Mepivacaine Hydrochloride (200 mg)
|
|
|
メプレドニゾン
販売終了
|
|
|
3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt (75 mg)
|
|
|
Mercaptopurine (500 mg)
|
|
|
Meropenem (300 mg)
|
|
|
Mesalamine (200 mg)
|
|
|
Mesna (200 mg)
|
|
|
Mesna Related Compound A (50 mg) (2-(Acetylthio)ethane-1-sulfonic acid, potassium salt, crystal adduct with potassium chloride)
|
|
|
Mesna Related Compound B (50 mg) (2,2'-Disulfanediylbis(ethane-1-sulfonic acid), dipotassium salt, crystal adduct with sodium chloride)
|
|
|
Mesoridazine Besylate (25 mg)
|
|
|
Mestranol (200 mg)
|
|
|
Metacresol (1 mL)
|
|
|
Metaproterenol Sulfate (200 mg)
|
|
|
Metaraminol Bitartrate (200 mg)
|
|
|
Metaxalone (200 mg)
|
|
|
Metaxalone Related Compound A (10 mg) (4-((3,5-dimethylphenoxy)methyl)imidazolidin-2-one)
|
|
|
Metaxalone Related Compound B (25 mg) (1-amino-3-(3,5-dimethylphenoxy)propan-2-ol)
|
|
|
Metaxalone Related Compound C (25 mg) (Bis[2-hydroxy-3-(3,5-dimethylphenoxy)propyl]amine)
|
|
|
Metformin Hydrochloride (200 mg)
|
|
|
Metformin Related Compound A (30 mg) (1-Cyanoguanidine)
|
|
|
Metformin Related Compound B (25 mg) (1-Methylbiguanide hydrochloride)
|
|
|
Metformin Related Compound C (25 mg) (N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine)
|
|
|
Methacholine Chloride (5 x 150 mg)
|
|
|
Methacrylic Acid and Methyl Methacrylate Copolymer (1:1) (200 mg) (Methacrylic Acid Copolymer Type A)
|
|
|
Methacrylic Acid and Methyl Methacrylate Copolymer (1:2) (200 mg) (Methacrylic Acid Copolymer, Type B)
|
|
|
Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) (Methacrylic Acid Copolymer Type C) (200 mg)
|
|
|
Methacycline Hydrochloride (200 mg)
|
|
|
Methazolamide (500 mg)
|
|
|
メトジラジン塩酸塩
販売終了
|
|
|
Methenamine (100 mg)
|
|
|
Methenamine Hippurate (200 mg)
|
|
|
Methenamine Mandelate (200 mg)
|
|
|
Methimazole (200 mg)
|
|
|
Methimazole Related Compound A (3 x 50 mg) (2,2-Dimethoxy-N-methylethanamine)
|
|
|
Methimazole Related Compound C (3 x 50 mg) (1-Methyl-2-(methylthio)-1H-imidazole)
|
|
|
L-Methionine (200 mg)
|
|
|
Methocarbamol (200 mg)
|
|
|
Methotrexate (500 mg)
|
|
|
Methotrexate Related Compound B (75 mg) ((S)-2-{4-[(2,4-diaminopteridin-6-yl)methylamino]benzamido}pentanedioic acid)
|
|
|
Methotrexate Related Compound C (50 mg) ((S)-2-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl](methyl)amino}benzamido) pentanedioic acid)
|
|
|
Methotrexate Related Compound E (50 mg) (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
|
|
|
Methotrimeprazine (200 mg)
|
|
|
Methoxsalen (200 mg)
|
|
|
メトキシフルラン
販売終了
|
|
|
Methoxymethylguanine (20 mg)
|
|
|
Methscopolamine Bromide (200 mg) (6Beta,7Beta-Epoxy-3alpha-hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide (-)-tropate)
|
|
|
Methsuximide (500 mg)
|
|
|
Methyclothiazide (200 mg)
|
|
|
Methyclothiazide Related Compound A (50 mg) (4-Amino-6-chloro-N-3-methyl-m-benzenedisulfonamide)
|
|
|
Methyl Acetate (1.2 mL/ampule; 3 ampules)
|
|
|
9-Methylacridine (25 mg)
|
|
|
Methyl Alcohol (3 x 1.5 mL)
|
|
|
3-Methyl-1-butanol (1.2 mL/ampule; 3 ampules)
|
|
|
Methylbenzhydrol (50 mg) (2-Methylbenzhydrol)
|
|
|
Methylbenzethonium Chloride (200 mg)
|
|
|
Enzacamene (200 mg) (1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one)
|
|
|
Methyl Caprate (3 x 100 mg)
|
|
|
Methyl Caproate (3 x 100 mg)
|
|
|
Methyl Caprylate (300 mg)
|
|
|
メチルセルロース (AS)
販売終了
|
|
|
Methylcobalamin (2 x 150 mg)
|
|
|
Methyldopa (500 mg)
|
|
|
メチルドーパート塩酸塩
販売終了
|
|
|
Methyldopa Related Compound B (10 mg) ((S)-2-Amino-3-(4-methoxyphenyl)-2-methylpropanoic acid hydrochloride)
|
|
|
Methyldopa Related Compound C (20 mg) ((S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid hydrochloride monohydrate)
|
|
|
Methylene Blue (750 mg)
|
|
|
Methylene Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate)
|
|
|
Methylenediurea (300 mg) (1,1'-Methylenediurea)
|
|
|
Methyl Ethyl Ketone (1.2 mL/ampule; 3 ampules)
|
|
|
Methyl Isobutyl Ketone (1.2 mL/ampule; 3 ampules)
|
|
|
Methyl Laurate (5 x 100 mg)
|
|
|
Methyl Linoleate (5 x 50 mg)
|
|
|
Methyl Linolenate (5 x 50 mg) (COLD SHIPMENT REQUIRED)
|
|
|
3-O-Methylmethyldopa (50 mg)
|
|
|
Methylnaltrexone Bromide (100 mg)
|
|
|
6-Methylnicotinic Acid (50 mg)
|
|
|
Methyl 12-Hydroxystearate (200 mg)
|
|
|
Methyl Myristate (3 x 100 mg)
|
|
|
Methyl Oleate (5 x 100 mg)
|
|
|
Methyl Palmitate (3 x 100 mg)
|
|
|
Methyl Palmitoleate (3 x 100 mg)
|
|
|
Methylparaben (125 mg)
|
|
|
Methylphenidate Related Compound A (50 mg) (alpha-Phenyl-2-piperidineacetic Acid Hydrochloride)
|
|
|
Methylprednisolone (200 mg)
|
|
|
Methylprednisolone Related Compound A (25 mg) (17,21-Dihydroxy-6alpha-methylpregna-1,4-diene-3,11,20-trione)
|
|
|
Methylprednisolone Related Compound C (25 mg) (11beta-Hydroxy-6alpha-methylandrosta-1,4-diene-3,17-dione)
|
|
|
Methylprednisolone Acetate (200 mg)
|
|
|
Methylprednisolone Hemisuccinate (250 mg)
|
|
|
2-Methyl-1-propanol (1.2 mL/ampule; 3 ampules)
|
|
|
Methylpyrrolidone (2 g)
|
|
|
Methyl Ricinoleate (100 mg)
|
|
|
Methyl Salicylate (2 mL)
|
|
|
Methyl Salicylate Related Compound A (50 mg) (Dimethyl 4-hydroxyisophthalate)
|
|
|
Methyl Stearate (275 mg)
|
|
|
Methylsulfonylmethane (200 mg)
|
|
|
Methyl Tricosanoate (200 mg) (Tricosanoic acid, methyl ester)
|
|
|
Methysergide Maleate (350 mg)
|
|
|
Metoclopramide Hydrochloride (500 mg)
|
|
|
Metoclopramide Related Compound A (15 mg) (4-Acetamido-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide)
|
|
|
Metoclopramide Related Compound B (15 mg) (Methyl 4-acetamido-5-chloro-2-methoxybenzoate)
|
|
|
Metoclopramide Related Compound D (15 mg) (Methyl 4-acetamido-2-methoxybenzoate)
|
|
|
Metolazone (200 mg)
|
|
|
Metoprolol Related Compound A (20 mg) ((+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol)
|
|
|
Metoprolol Related Compound B (100 mg) ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane)
|
|
|
Metoprolol Related Compound C (15 mg) (4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride)
|
|
|
Metoprolol Related Compound D (50 mg) ((+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl](1-methylethyl)amine hydrochloride)
|
|
|
Metoprolol Fumarate (200 mg)
|
|
|
Metoprolol Succinate (200 mg)
|
|
|
Metoprolol Tartrate (200 mg)
|
|
|
Metronidazole (100 mg)
|
|
|
Metronidazole Benzoate (100 mg)
|
|
|
Metyrapone (200 mg)
|
|
|
Metyrosine (200 mg)
|
|
|
Mexiletine Hydrochloride (200 mg)
|
|
|
Miconazole (200 mg)
|
|
|
Miconazole Related Compound C (50 mg) (2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethan-1-amine hydrochloride)
|
|
|
Miconazole Related Compound F (50 mg) (1-{2-[(3,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole)
|
|
|
Miconazole Related Compound I (50 mg) (1-{2-[(2-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole mononitrate)
|
|
|
Miconazole Nitrate (200 mg)
|
|
|
Milnacipran Hydrochloride (250 mg)
|
|
|
Milnacipran Related Compound A (25 mg) (2-(Aminomethyl)-1-phenylcyclopropane-1-carboxylic acid hydrochloride)
|
|
|
Milnacipran Related Compound B (25 mg) (1-Phenyl-3-azabicyclo[3.1.0]hexan-2-one)
|
|
|
Milnacipran Related Compound C (25 mg) ((1RS ,2SR)-2-[(1,3-Dioxoisoindolin-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropane-1-carboxamide)
|
|
|
Midodrine Hydrochloride (200 mg)
|
|
|
Midodrine Related Compound A (40 mg) (1-(2,5 Dimethoxyphenyl)-2-aminoethanol)
|
|
|
Mifepristone (200 mg)
|
|
|
Milbemycin Oxime (200 mg)
|
|
|
Milrinone (500 mg)
|
|
|
Milrinone Related Compound A (50 mg) (1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carboxamide)
|
|
|
Mineral Oil (1.5 mL)
|
|
|
Minocycline Hydrochloride (350 mg)
|
|
|
Minoxidil (125 mg)
|
|
|
Minoxidil Related Compound E (25 mg) (6-(Piperidin-1-yl)pyrimidine-2,4-diamine)
|
|
|
Mirtazapine Related Compound B (25 mg) (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate)
|
|
|
Mirtazapine Related Compound C (50 mg) (2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one)
|
|
|
Mirtazapine Related Compound D (50 mg) (2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one)
|
|
|
Mirtazapine (350 mg)
|
|
|
Mirtazapine Related Compound A (25 mg) (1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine)
|
|
|
Mirtazapine Resolution Mixture (25 mg) (This mixture contains mirtazapine, impurity A, impurity B, impurity C, impurity D, impurity E and impurity F)
|
|
|
Misoprostol (100 mg)
|
|
|
Mitomycin (50 mg)
|
|
|
Mitotane (500 mg)
|
|
|
Mitoxantrone Hydrochloride (400 mg)
|
|
|
Mitoxantrone System Suitability Mixture (0.3 mg) (Mixture of 0.2 mg 1-Amino-5,8-dihydroxy-4-({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione hydrochloride and 0.1 mg Mitoxantrone Hydrochloride)
|
|
|
Modafinil Related Compound A (20 mg) (2-[(diphenylmethyl)sulfinyl]acetic acid)
|
|
|
Modafinil Related Compound B (2-[(ジフェニルメチル)スルホニル]アセトアミド)
販売終了
|
|
|
Modafinil Related Compound D (DISCONTINUED)
販売終了
|
|
|
Modafinil Related Compound E (Bis(diphenylmethyl)disulfide)
販売終了
|
|
|
Moexipril Hydrochloride (100 mg)
|
|
|
Mogroside V (100 mg)
|
|
|
Molindone Hydrochloride (500 mg)
|
|
|
Mometasone Furoate (200 mg)
|
|
|
Monensin Sodium (200 mg)
|
|
|
Monk Fruit Extract (500 mg)
|
|
|
Monobenzone (200 mg)
|
|
|
Moexipril Related Compound A (20 mg) ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid)
|
|
|
Moexipril Related Compound B (20 mg) ((S)-ethyl 2-{(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H-pyrazino[1,2-b]isoquinolin-2(6H,11H,11aH)-yl}-4-phenylbutanoate)
|
|
|
Moexipril Related Compound C (20 mg) ((S)-tert-butyl 2-{(S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, maleate)
|
|
|
Moexipril Related Compound D (20 mg) ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride)
|
|
|
Moexipril Related Compound E (20 mg) ((S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride)
|
|
|
Moexipril Related Compound F (20 mg) ((S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoic acid)
|
|
|
Moexipril Related Compound G (20 mg) ((S)-6,7-dimethoxy-2-{(S)-2-[(S)-1-methoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride)
|
|
|
Monoethanolamine (1 mL)
|
|
|
Monoglycerides (125 mg)
|
|
|
Monosodium Glutamate (500 mg) (Monosodium L-glutamate, monohydrate)
|
|
|
Monostearyl Maleate (100 mg)
|
|
|
Montelukast Dicyclohexylamine (150 mg)
|
|
|
Montelukast for Peak Identification (20 mg)
|
|
|
Montelukast Racemate (20 mg)
|
|
|
Montelukast Sodium (50 mg)
|
|
|
Morantel Tartrate (100 mg)
|
|
|
Moricizine Hydrochloride (250 mg)
|
|
|
Moxidectin (200 mg)
|
|
|
Moxidectin System Suitability Mixture (50 mg)
|
|
|
Moxifloxacin Hydrochloride (200 mg)
|
|
|
Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
|
|
|
Moxifloxacin Related Compound B (25 mg) (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate)
|
|
|
Moxifloxacin Related Compound C (25 mg) (1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate)
|
|
|
Moxifloxacin Related Compound D (15 mg) (1-Cyclopropyl-8-fluoro-6-methoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
|
|
|
Moxifloxacin Related Compound E (25 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride)
|
|
|
Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
|
|
|
Moxifloxacin Related Compound G (15 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride)
|
|
|
Mupirocin (50 mg)
|
|
|
Mupirocin Calcium (200 mg)
|
|
|
Mupirocin Lithium (100 mg)
|
|
|
Mycophenolate Mofetil (200 mg)
|
|
|
Mycophenolate Mofetil Related Compound A (15 mg) (2-Morpholinoethyl (E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate)
|
|
|
Mycophenolate Mofetil Related Compound B (15 mg) [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one]
|
|
|
Mycophenolate Sodium (200 mg)
|
|
|
Myristic Acid (200 mg)
|
|
|
Myristyl Alcohol (5 x 100 mg)
|
|
|
Maritime Pine Extract (1.5 g)
|
|
|
Monobasic Potassium Phosphate (5 g)
|
|
|
Meso-Zeaxanthin (5x 30 mg)
|
|
